VCV000855582.9 - ClinVar - NCBI (2024)

Advanced search

On this page
  • Classification Summary
  • Variant Details
  • Genes
  • Germline
  • Conditions
  • Submissions
  • Text mined Citations

NM_007194.4(CHEK2):c.1334A>G (p.Tyr445Cys)

Germline

Classification Help

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2) Help

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Uncertain significance

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_007194.4(CHEK2):c.1334A>G (p.Tyr445Cys)

Variation ID: 855582 Accession: VCV000855582.9

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 22q12.1 22: 28695168 (GRCh38) [ NCBI UCSC ] 22: 29091156 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar
First in ClinVar Help

The date this variant first appeared in ClinVar with each type of classification.

Last submission Help

The date of the most recent submission for each type of classification for this variant.

Last evaluated Help

The most recent date that a submitter evaluated this variant for each type of classification.

Germline Apr 15, 2020 Feb 20, 2024 Aug 25, 2023
HGVS
Nucleotide Protein Molecular
consequence
NM_007194.4:c.1334A>G MANESelect Help

Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.

NP_009125.1:p.Tyr445Cys missense
NM_001005735.2:c.1463A>G NP_001005735.1:p.Tyr488Cys missense
NM_001257387.2:c.671A>G NP_001244316.1:p.Tyr224Cys missense
NM_001349956.2:c.1133A>G NP_001336885.1:p.Tyr378Cys missense
NM_145862.2:c.1247A>G NP_665861.1:p.Tyr416Cys missense
NC_000022.11:g.28695168T>C
NC_000022.10:g.29091156T>C
NG_008150.2:g.51699A>G
LRG_302:g.51699A>G
LRG_302t1:c.1334A>G LRG_302p1:p.Tyr445Cys
... more HGVS ... less HGVS
Protein change
Y416C, Y488C, Y378C, Y224C, Y445C
Other names
-
Canonical SPDI
NC_000022.11:28695167:T:C
Functional
consequence Help

The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

-

Global minor allele
frequency (GMAF) Help

The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

-

Allele frequency Help

The frequency of the allele represented by this VCV record.

-

Links
dbSNP: rs778246892
VarSome

Genes

Gene OMIM ClinGen Gene Dosage Sensitivity Curation Variation Viewer Help

Links to Variation Viewer, a genome browser to view variation data from NCBI databases.

Related variants
HI score Help

The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.

TS score Help

The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.

Within gene Help

The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.

All Help

The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.

CHEK2 Sufficient evidence for dosage pathogenicity No evidence available GRCh38
GRCh37
3945 3999

Conditions - Germline

Condition Help

The condition for this variant-condition (RCV) record in ClinVar.

Classification Help

The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses.


(# of submissions)
Review status Help

The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.

Last evaluated Help

The most recent date that a submitter evaluated this variant for the condition.

Variation/condition record Help

The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.

Familial cancer of breast

Uncertain significance (1) Oct 7, 2022 RCV001060876.7

Hereditary cancer-predisposing syndrome

Uncertain significance (1) Aug 25, 2023 RCV003353138.1

Submissions - Germline

Classification Help

The submitted germline classification for each SCV record.


(Last evaluated)
Review status Help

Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method.


(Assertion criteria)
Condition Help

The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.

Submitter Help

The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.

More information Help

This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.

Uncertain significance

(Aug 25, 2023)

(Ambry General Variant Classification Scheme_2022)

Method: clinical testing

Hereditary cancer-predisposing syndrome

Affected status: unknown

Allele origin: germline

Ambry Genetics

Accession: SCV004055698.1
First in ClinVar: Oct 28, 2023
Last updated: Oct 28, 2023

Comment:

The p.Y445C variant (also known as c.1334A>G), located in coding exon 11 of the CHEK2 gene, results from an A to G substitution at nucleotide … (more)

The p.Y445C variant (also known as c.1334A>G), located in coding exon 11 of the CHEK2 gene, results from an A to G substitution at nucleotide position 1334. The tyrosine at codon 445 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)

Uncertain significance

(Oct 07, 2022)

(Invitae Variant Classification Sherloc (09022015))

Method: clinical testing

Familial cancer of breast

Affected status: unknown

Allele origin: germline

Invitae

Accession: SCV001225592.5
First in ClinVar: Apr 15, 2020
Last updated: Feb 20, 2024

Comment:

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more)

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 855582). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 445 of the CHEK2 protein (p.Tyr445Cys). (less)

Comment:

The p.Y445C variant (also known as c.1334A>G), located in coding exon 11 of the CHEK2 gene, results from an A to G substitution at nucleotide position 1334. The tyrosine at codon 445 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Comment:

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 855582). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 445 of the CHEK2 protein (p.Tyr445Cys).

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

The p.Y445C variant (also known as c.1334A>G), located in coding exon 11 of the CHEK2 gene, results from an A to G substitution at nucleotide position 1334. The tyrosine at codon 445 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Comment:

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 855582). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 445 of the CHEK2 protein (p.Tyr445Cys).

Citations for germline classification of this variant

Help

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for rs778246892 ...

Help

These citations are identified by LitVar using the rs number, so they may include citations for more than one variant at this location. Please review the LitVar results carefully for your variant of interest.

Record last updated Feb 20, 2024

Help

VCV000855582.9 - ClinVar - NCBI (2024)

FAQs

Is ClinVar reliable? ›

ClinVar can be a reliable resource supporting variant interpretation, quality assessment, and clinical practice when factors uncovered in this study are taken into account.

How to cite ncbi ClinVar? ›

Citing ClinVar

ClinVar records should be referred to with accession and version numbers. It important to include the version number because the classification may change over time; the version number allows you to distinguish between previous and current versions.

What is ClinVar in NCBI? ›

ClinVar aggregates information about genomic variation and its relationship to human health.

Is DNA health testing accurate? ›

The quality and accuracy of these tests is unknown. Be wary of companies that sell supplements or fitness products based on the results of genetic testing. These are generally not proven to have any health benefit.

Where does ClinVar data come from? ›

ClinVar is built from data provided by submitters. ClinVar is not staffed to review the literature to build content via curation. We gratefully acknowledge all those who contribute their data.

Can I reference NCBI? ›

To acknowledge NCBI services in your writing, you can refer to (1) publications that NCBI staff publishes in peer-reviewed journals or (2) to the NCBI web site (internet) and individual services/records within the site.

What is ClinVar used for? ›

‍ClinVar is a freely accessible, public archive of reports of the relationships among human genetic variations and phenotypes, with supporting evidence. Essentially, this means it's an archive of variants associated with a gene. Variants are submitted typically by major diagnosing laboratories and research centers.

How big is ClinVar database? ›

The database holds 600,000 submitted records from 1,000 submitters, representing 430,000 unique variants.

What is the difference between VCV and RCV in ClinVar? ›

RCV (Reference ClinVar record - data aggregated by variant-condition pair) VCV (Variation ClinVar record - data aggregated by variant)

What is the ClinVar summary? ›

ClinVar is a freely accessible, public archive of reports of human variations classified for diseases and drug responses, with supporting evidence.

Who can submit to ClinVar? ›

ClinVar welcomes submissions from: clinical testing labs. research labs. genetics clinics.

How do I download ClinVar data? ›

Data in ClinVar may be searched and browsed on the website (https://www.ncbi.nlm.nih.gov/clinvar/) and downloaded from the ftp site (ftp.ncbi.nlm.nih.gov/pub/clinvar/). Programmatic access is also available using NCBI's E-utilities and Entrez direct (https://www.ncbi.nlm.nih.gov/books/NBK25501/).

How many VUS are in ClinVar? ›

Whiffin et al. curated 43 variants classified in ClinVar as pathogenic (P)/likely pathogenic (LP) that were insufficiently rare in at least one ExAC population and found that 42 of them should be reclassified as variant of uncertain significance (VUS)6.

How to reference ClinVar? ›

If you distribute or copy data from ClinVar, we ask that you provide attribution to ClinVar as a data source in publications and websites.
  1. You can cite of one the ClinVar publications (e.g. PMID: 29165669)
  2. Websites should display the "Powered by NCBI" logo:
Mar 23, 2020

Is ClinVar curated? ›

However ClinVar neither curates submitted content nor modifies classifications independent of an explicit submission. If you have data that differs from what is currently represented in ClinVar, we encourage you to submit your data and the evidence supporting your classification.

What is the difference between ClinVar and HGMD? ›

HGMD includes only mutations that have been shown to be disease-associated, while ClinVar includes variants regardless of whether or not they have been shown to be disease-associated.

What is the difference between ClinVar and ClinGen? ›

ClinVar is a critical resource for ClinGen. It serves as the primary site for deposition and retrieval of variant data and annotations from individual submitters. ClinGen relies on ClinVar as a source for existing data on variants, which are submitted to ClinVar from diverse sources.

What does benign ClinVar mean? ›

Likely Benign - It is likely that this genetic change does not impact a gene's function. More evidence might help say this more definitively. Likely benign variants likely do not independently impact health. Benign - This genetic change is not thought to impact gene function and independently cause disease.

References

Top Articles
Latest Posts
Article information

Author: Sen. Ignacio Ratke

Last Updated:

Views: 5837

Rating: 4.6 / 5 (56 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Sen. Ignacio Ratke

Birthday: 1999-05-27

Address: Apt. 171 8116 Bailey Via, Roberthaven, GA 58289

Phone: +2585395768220

Job: Lead Liaison

Hobby: Lockpicking, LARPing, Lego building, Lapidary, Macrame, Book restoration, Bodybuilding

Introduction: My name is Sen. Ignacio Ratke, I am a adventurous, zealous, outstanding, agreeable, precious, excited, gifted person who loves writing and wants to share my knowledge and understanding with you.